GGrantIndex
← Leaderboards

Anatoliy I Yashin

Duke University

$18,815,780
Attributed
$22,021,201
Total exposure
12
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $16M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$46,746,832 · 14

By mechanism

U19$16,011,689 · 1
R01$15,136,654 · 8
P01$12,515,058 · 4
RF1$3,083,431 · 1

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposLongevityAgingGeneticLinkMalignant NeoplasmsIndexingGenesAffectDiabetes MellitusPhysiologicalPatternElderlyData SetStrokeS DiseaseSmokingAge RelatedCharacteristicsGenetic VariantMortality Vital StatisticsBiologicalCohortLife

Grant awards (60)

The Long Life Family Study$15,098,513
U19 · FY2025 · AG
The Long Life Family Study$913,176
U19 · FY2025 · AG
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$563,851
R01 · FY2024 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$563,851
R01 · FY2023 · AG · contact PI
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$490,438
R01 · FY2023 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$564,530
R01 · FY2022 · AG · contact PI
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$495,911
R01 · FY2022 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$564,530
R01 · FY2021 · AG · contact PI
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$497,521
R01 · FY2021 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$564,530
R01 · FY2020 · AG · contact PI
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$502,969
R01 · FY2020 · AG · contact PI
Genetics of changes in population pyramids: Implications for health forecasting with a focus on Alzheimer's Disease and related dementias$3,083,431
RF1 · FY2019 · AG · contact PI
Relationships among Genetic Regulators of Aging Health and Lifespan$1,755,717
P01 · FY2018 · AG · contact PI
Genetics of Changes in Population Pyramids: Implications for Health Forecasting$582,137
R01 · FY2018 · AG · contact PI
GENES AND NON-GENETIC FACTORS AFFECTING LIFESPAN: EFFECTS ON HEALTH AND AGING$378,114
P01 · FY2018 · AG · contact PI
ADMINISTRATIVE CORE$169,443
P01 · FY2018 · AG · contact PI
Relationships among Genetic Regulators of Aging Health and Lifespan$1,755,231
P01 · FY2017 · AG · contact PI
Genetics of Changes in Population Pyramids: Implications for Health Forecasting$582,137
R01 · FY2017 · AG · contact PI
GENES AND NON-GENETIC FACTORS AFFECTING LIFESPAN: EFFECTS ON HEALTH AND AGING$378,112
P01 · FY2017 · AG · contact PI
ADMINISTRATIVE CORE$169,448
P01 · FY2017 · AG · contact PI
Relationships among Genetic Regulators of Aging Health and Lifespan$1,754,501
P01 · FY2016 · AG · contact PI
Genetics of Changes in Population Pyramids: Implications for Health Forecasting$582,137
R01 · FY2016 · AG · contact PI
GENES AND NON-GENETIC FACTORS AFFECTING LIFESPAN: EFFECTS ON HEALTH AND AGING$378,114
P01 · FY2016 · AG · contact PI
ADMINISTRATIVE CORE$169,443
P01 · FY2016 · AG · contact PI
YASHIN Admin Supp: Time Trends in Alzheimer's Disease: Addressing the Changing Role of Risk Factors and Instrument Validity$159,000
R01 · FY2016 · AG · contact PI
Relationships among Genetic Regulators of Aging Health and Lifespan$1,696,517
P01 · FY2015 · AG · contact PI
Genetics of Changes in Population Pyramids: Implications for Health Forecasting$564,674
R01 · FY2015 · AG · contact PI
GENES AND NON-GENETIC FACTORS AFFECTING LIFESPAN: EFFECTS ON HEALTH AND AGING$370,033
P01 · FY2015 · AG · contact PI
ADMINISTRATIVE CORE$164,019
P01 · FY2015 · AG · contact PI
Relationships among Genetic Regulators of Aging Health and Lifespan$1,751,976
P01 · FY2014 · AG · contact PI
Genetics of Changes in Population Pyramids: Implications for Health Forecasting$595,011
R01 · FY2014 · AG · contact PI
GENES AND NON-GENETIC FACTORS AFFECTING LIFESPAN: EFFECTS ON HEALTH AND AGING$382,028
P01 · FY2014 · AG · contact PI
ADMINISTRATIVE CORE$180,187
P01 · FY2014 · AG · contact PI
The future of major geriatric disorders in the US elderly$177,938
R01 · FY2012 · AG · contact PI
EVALUATING NEW GENETIC EFFECTS ON HEALTH AND AGING FROM LONGITUDINAL DATA$552,495
R01 · FY2011 · AG · contact PI
The future of major geriatric disorders in the US elderly$177,829
R01 · FY2011 · AG · contact PI
The future of major geriatric disorders in the US elderly$137,868
R01 · FY2011 · AG · contact PI
EVALUATING NEW GENETIC EFFECTS ON HEALTH AND AGING FROM LONGITUDINAL DATA$583,338
R01 · FY2010 · AG · contact PI
New Methods of Studying Aging, Health and Longevity: Combining Longitudinal Data$389,421
R01 · FY2010 · AG · contact PI
The future of major geriatric disorders in the US elderly$185,066
R01 · FY2010 · AG · contact PI
EVALUATING NEW GENETIC EFFECTS ON HEALTH AND AGING FROM LONGITUDINAL DATA$587,756
R01 · FY2009 · AG · contact PI
New Methods of Studying Aging, Health and Longevity: Combining Longitudinal Data$390,000
R01 · FY2009 · AG · contact PI
DYNAMIC DETERMINANTS OF EXCEPTIONAL HEALTH AT LATE AGES$341,186
R01 · FY2009 · AG · contact PI
Healthy Life at Risk: The Role of Senescence$242,602
R01 · FY2009 · AG · contact PI
The future of major geriatric disorders in the US elderly$186,982
R01 · FY2009 · AG · contact PI
EVALUATING NEW GENETIC EFFECTS ON HEALTH AND AGING FROM LONGITUDINAL DATA$582,132
R01 · FY2008 · AG · contact PI
DYNAMIC DETERMINANTS OF EXCEPTIONAL HEALTH AT LATE AGES$336,975
R01 · FY2008 · AG · contact PI
Healthy Life at Risk: The Role of Senescence$233,147
R01 · FY2008 · AG · contact PI
The future of major geriatric disorders in the US elderly$186,741
R01 · FY2008 · AG · contact PI
DYNAMICS OF AGING AND EXTREME LONGEVITY$167,093
P01 · FY2008 · AG · contact PI
EVALUATING NEW GENETIC EFFECTS ON HEALTH AND AGING FROM LONGITUDINAL DATA$600,159
R01 · FY2007 · AG · contact PI
DYNAMIC DETERMINANTS OF EXCEPTIONAL HEALTH AT LATE AGES$336,191
R01 · FY2007 · AG · contact PI
DYNAMICS OF AGING AND EXTREME LONGEVITY$237,367
P01 · FY2007 · AG · contact PI
Healthy Life at Risk: The Role of Senescence$231,669
R01 · FY2007 · AG · contact PI
DYNAMIC DETERMINANTS OF EXCEPTIONAL HEALTH AT LATE AGES$343,161
R01 · FY2006 · AG · contact PI
Healthy Life at Risk: The Role of Senescence$230,740
R01 · FY2006 · AG · contact PI
DYNAMICS OF AGING AND EXTREME LONGEVITY$221,585
P01 · FY2006 · AG · contact PI
Healthy Life at Risk: The Role of Senescence$230,031
R01 · FY2005 · AG
DYNAMICS OF AGING AND EXTREME LONGEVITY$215,132
P01 · FY2005 · AG
DYNAMICS OF AGING AND EXTREME LONGEVITY$220,998
P01 · FY2004 · AG